State Of Wyoming Ultragenyx Pharmaceutical Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $458 - $854	10 Added 35.71%	38 $2,000
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $248 - $337	4 Added 16.67%	28 $2,000
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $73 - $87	-1 Reduced 4.0%	24 $2,000
Q3 2021 Feb 11, 2022	SELL	$77.92 - $102.4 $1,012 - $1,331	-13 Reduced 34.21%	25 $2,000
Q2 2021 Feb 11, 2022	BUY	$92.19 - $115.71 $1,843 - $2,314	20 Added 111.11%	38 $4,000
Q1 2021 Feb 08, 2022	BUY	$106.9 - $167.73 $1,924 - $3,019	18 New	18 $2,000

344

84.3M

675K

846K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.71B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.